BioSpace News Archive

Parkinson’s Disease Treatment Market Size, Share | Report 2022-2030

The global Parkinson’s disease treatment market size was estimated at around USD 4.3 billion in 2021 and it is projected to hit around USD 12.1 billion by 2030, growing at a CAGR of 12.18% from 2022 to 2030.

November 10, 2022
·
8 min read
Rare Neurodegenerative Disease Treatment Market Size, Report 2022-2030

According to Vision Research Reports, the global rare neurodegenerative disease treatment market size was valued at US$ 79.61 billion in 2021 and is expected to grow at a CAGR of 5.2% from 2022 to 2030.

November 10, 2022
·
6 min read
Respiratory Antiviral Treatment Market Size to Hit US$ 5.4 Billion by 2030

According to latest report, the global respiratory antiviral treatment market size was reached at US$ 3 Bn in 2020 and is predicted to hit US$ 5.4 billion by 2030.

November 10, 2022
·
10 min read
Biotech Bay

Invitae Showcases Advances in Medical Genomics at the National Society of Genetic Counselors (NSGC) 41st Annual Conference

Researchers from Invitae (NYSE: NVTA), a leading medical genetics company, are presenting research next week at the National Society of Genetic Counselors (NSGC) 41st Annual Conference in Nashville.

November 10, 2022
·
6 min read
Retinal Disorders Treatment Market Size, Trends, CAGR, Report 2022 to 2030

In 2021, the global retinal disorders treatment market value reached at US$ 9.99 billion and projected to hit US$ 19 billion by 2030, expanding growth at a CAGR of 7.1% from 2022 to 2030.

November 10, 2022
·
7 min read
Vagus Nerve Stimulation Market Size, Share | Report 2022-2030

According to Vision Research Reports, the global vagus nerve stimulation market was valued at USD 673.02 million in 2021 and it is predicted to surpass around USD 1.59 billion by 2030 with a CAGR of 10.03% from 2022 to 2030.

November 10, 2022
·
7 min read
Von Willebrand Disease Treatment Market Size to Reach US$ 905 Million by 2030

The von willebrand disease treatment market size is predicted to reach US$ 905 million by 2030 from US$ 502.88 million in 2021, expanding growth at a CAGR of 6.1% from 2021 to 2030.

November 10, 2022
·
9 min read
Respiratory Virus Vaccines Market Size to Hit Around US$ 14.6 Bn by 2030

According to Vision Research Reports, the global respiratory virus vaccines market size is projected to hit around US$ 14.6 billion by 2030 from US$ 3.2 billion in 2020, growth is expanding at a CAGR of 8.1% from 2021 to 2030.

November 10, 2022
·
8 min read
Business

Enable Injections Enhances Board with Addition of Nigel Sheail

Enable Injections, Inc., a company developing and manufacturing the enFuse® platform of investigational wearable drug delivery systems, is pleased to announce the appointment of Nigel Sheail to the company’s Board of Directors, effective October 27, 2022.

November 10, 2022
·
2 min read
Business

Biostage Schedules Conference Call and Webcast for Q3 2022 Results

Biostage, Inc. (OTCQB: BSTG) (“Biostage” or the “Company”) today announced that it will release Q3 2022 financial results on November 14, 2022 and host a conference call and webcast on November 15, 2022 at 9:00 AM ET to discuss financial results and business updates for the third-quarter 2022.

November 10, 2022
·
3 min read